Stock Analiz

ReposiTrak, Inc. TRAK

EDP Services · data as of November 13, 2026

$7.32Market cap $136M
Open the interactive analysis →

ReposiTrak, Inc. (TRAK) is a technology company listed in the US with a market value of about $136M. In fiscal year 2026 it had revenue of $23M and net income of $8M, a net margin of 32.5%.

Its overall Stock Analiz score is 3.2 out of 5 (average). The strongest part is financial health (5/5); the weakest is future growth (1/5).

Key numbers: a P/E of 18.0, a price to free cash flow of 16.6, 5-year revenue growth of 2% a year, a 5-year average ROIC of 11%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 30% below the current price.

About ReposiTrak

ReposiTrak is listed in the US and classified in edp services. Revenue went from $14M in 2015 to $23M in 2026, growth of about 5.0% a year. It was profitable in 10 of the last 10 years in our data.

Score: 3.2 / 5

Value4/5
Future growth1/5
Track record2/5
Financial health5/5
Shareholder returns4/5

Checks passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • PEG below 1.5
  • Profit margin improving
  • 5-year EPS growth above 10% a year
  • Profitable 5 years in a row
  • More cash than debt, or low debt to equity

Checks not passed

  • Price below intrinsic value (DCF, moderate assumptions)
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • 3-year free cash flow growth above 10% a year
  • Strong R&D investment or growth above 20%
  • 5-year revenue growth above 8% a year
  • 5-year average ROIC above 12%
  • ROE above 15%

Valuation

P/E (TTM)18.0
Forward P/E—
P/FCF16.6
P/S5.8
P/B2.6
EV/EBITDA16.1
PEG1.08
Dividend yield1.20%
FCF yield6.0%
Shareholder yield2.5%
Intrinsic value vs. price−30%

Growth and quality

Revenue growth (1 yr)3.0%
Revenue growth (5 yrs, per year)2.1%
EPS growth (5 yrs, per year)16.7%
FCF growth (3 yrs, per year)-2.0%
Net margin (5-yr avg.)28.8%
ROIC (5-yr avg.)10.6%
Profitable years (of last 10)10
Years paying a dividend10

Financials, last 10 years

Fiscal year2026202520242023202220212020201920182017
Revenue$23M$23M$20M$19M$18M$21M$20M$21M$22M$19M
Net income$8M$7M$6M$6M$4M$4M$2M$4M$3M$4M
Free cash flow$8M$8M$7M$9M$6M$5M$4M$3M$2M$299736
EPS (diluted)$0.39$0.35$0.29$0.27$0.18$0.18$0.05$0.16$0.14$0.15
Net margin32.5%30.9%29.1%29.3%22.2%19.6%8.0%18.4%15.5%20.0%
ROIC11.9%11.3%10.0%10.3%9.3%6.2%3.2%8.7%8.2%10.0%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

What is ReposiTrak’s P/E ratio?

About 18.0, based on the last twelve months of diluted earnings per share.

Is ReposiTrak stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 30% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does ReposiTrak pay a dividend?

Yes. The dividend yield is about 1.20%, and it has paid dividends for 10 years in our data.

Is ReposiTrak a good stock to buy?

We do not give buy or sell advice. ReposiTrak scores 3.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.